---
title: "Influenza Vaccination Associated with Lower IMV and Death Risk in Older Hospitalized Adults — Fran"
id: "medrxiv-3-influenza-vaccination-and-disease-severity-among-older-adults-hospitalized-with"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-3-influenza-vaccination-and-disease-severity-among-older-adults-hospitalized-with"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.10.26367727v1?rss=1"
published_at: "2026-11-12T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Influenza Vaccination Associated with Lower IMV and Death Risk in Older Hospitalized Adults — Fran
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-3-influenza-vaccination-and-disease-severity-among-older-adults-hospitalized-with
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.10.26367727v1?rss=1)
- **Published At:** 2026-11-12T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Nationwide retrospective cohort using the French National Health Data System (SNDS) of adults aged ≥65 years hospitalized with confirmed influenza (ICD-10 J09 or J10) between October 2016 and December 2024, excluding 2020–2021. - Vaccination status derived from reimbursed community pharmacy dispensing records; pneumococcal and COVID-19 vaccination also accounted for in balancing. - The cohort comprised 132,443 influenza-associated hospitalizations; 72,852 (55%) occurred in patients recorded as vaccinated and 59,591 (45%) in unvaccinated patients. - Vaccinated patients were older on average (mean 82.3 years) versus unvaccinated (mean 79.3 years). - Primary clinical outcomes: **invasive mechanical ventilation (IMV)**, **ICU** admission, **in-hospital death**, and a composite severe outcome. - Entropy balancing used to adjust for sociodemographic factors, chronic conditions, and prior vaccinations; weighted regression provided adjusted risk ratios (aRRs). - IMV occurred in 2.9% of vaccinated hospitalizations (n=2,128) and 4.3% of unvaccinated (n=2,544); adjusted risk ratio (aRR) for IMV was 0.88 (95% CI 0.83–0.93) as reported. - In-hospital death occurred in 8.6% of vaccinated (n=6,300) and 8.3% of unvaccinated (n=4,952); investigators reported an aRR of 0.90 (95% CI 0.87–0.93). - Vaccination associated with a reduced risk of the composite severe outcome (aRR 0.96; 95% CI 0.94–0.98) but not with ICU admission (aRR 0.99; 95% CI 0.96–1.01). - Among ICU-admitted patients, vaccination corresponded to a lower hazard of death (adjusted HR 0.85; 95% CI 0.78–0.92) and to a median 2-day shorter time to discharge. - The study is a preprint and has not been peer reviewed; authors indicate data and code are available on request from the corresponding author and access to SNDS requires platform permission.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=EvVC01tCTOBWHoXXW_kaDB2B90.HO5Zs1aBpgJyo4wM-1794500320.9853015-1.2.1.1-E8oBoYks4Oz36ufPt7ZGZZcdnujVUIXVz_JZWJx3x5Y5IE7.qX.7mrmkl1udJDBy) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.10.26367727v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Influenza Vaccination and Disease Severity Among Older Adults Hospitalized with Influenza in France: A Nationwide Cohort Study, 2016-2024 Claire Nour Abou Chakra, Aby Ba Diallo, Andre Some, Baptiste Pitel, Helene Bricout, Clotilde EL GUERCHE-SEBLAIN, [ View ORCID Profile](http://orcid.org/0009-0005-2563-5816)Cecile Chauvel, [ View ORCID Profile](http://orcid.org/0000-0003-3788-878X)Marta Nunes doi: https://doi.org/10.64898/2026.11.10.26367727 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Claire Nour Abou Chakra 1 Universite Claude Bernard Lyon 1; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Claire%2BNour%2BAbou%2BChakra%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Abou%20Chakra%20CN&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AClaire%2BNour%2BAbou%2BChakra%2B) Aby Ba Diallo 2 Hospices Civils de Lyon; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Aby%2BBa%2BDiallo%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Diallo%20AB&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAby%2BBa%2BDiallo%2B) Andre Some 1 Universite Claude Bernard Lyon 1; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Andre%2BSome%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Some%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAndre%2BSome%2B) Baptiste Pitel 3 HEVA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Baptiste%2BPitel%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Pitel%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABaptiste%2BPitel%2B) Helene Bricout 4 Sanofi Vaccines; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Helene%2BBricout%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Bricout%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHelene%2BBricout%2B) Clotilde EL GUERCHE-SEBLAIN 5 Sanofi Pasteur * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Clotilde%2BEL%2BGUERCHE-SEBLAIN%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=EL%20GUERCHE-SEBLAIN%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AClotilde%2BEL%2BGUERCHE-SEBLAIN%2B) Cecile Chauvel 1 Universite Claude Bernard Lyon 1; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Cecile%2BChauvel%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Chauvel%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ACecile%2BChauvel%2B) * [ORCID record for Cecile Chauvel](http://orcid.org/0009-0005-2563-5816 "Open in new tab") Marta Nunes 2 Hospices Civils de Lyon; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Marta%2BNunes%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nunes%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMarta%2BNunes%2B) * [ORCID record for Marta Nunes](http://orcid.org/0000-0003-3788-878X "Open in new tab") * For correspondence: marta.nunes@chu-lyon.fr * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.10.26367727v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1343419/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.10.26367727v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1343419/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.10.26367727v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1343419/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.10.26367727v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1343419/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.10.26367727v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1343419/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Objective Seasonal influenza remains a major cause of severe morbidity and mortality among older adults, despite vaccine availability. We assessed whether influenza vaccination was associated with reduced disease severity among adults aged 65 years or more hospitalized with influenza in France. Methods and Analysis We conducted a nationwide retrospective cohort study using the French National Health Data System (SNDS). Adults aged 65 years or more hospitalized with confirmed influenza (ICD-10 codes: J09 or J10) between October 2016 and December 2024 were included, excluding 2020-2021. Vaccination status was identified from reimbursed community pharmacy dispensing records. Entropy balancing was used to balance sociodemographic characteristics, chronic conditions pneumococcal vaccination, and COVID-19 vaccination. Weighted regression models estimated adjusted risk ratios (aRRs) for invasive mechanical ventilation (IMV), intensive care unit (ICU) admission, in-hospital death, and a composite severe outcome. Multistate survival models assessed transitions specific hazard ratios (HR) between hospitalization, ICU, discharge, and in-hospital death. Results Among 132,443 influenza-associated hospitalizations, 72,852 (55%) occurred among vaccinated patients and 59,591 (45%) among unvaccinated patients. Vaccinated patients were older (mean age, 82.3 vs 79.3 years). IMV occurred in 2128 vaccinated (2.9%) and 2544 unvaccinated (4.3%) hospitalizations (aRR, 0.88; 95%CI: 0.83 to 0.93). In-hospital death occurred in 6300 (8.6%) and 4952 (8.3%), respectively (aRR, 0.90; 95%CI: 0.87 to 0.93). Vaccination was also associated with a lower risk of the composite outcome (aRR, 0.96; 95%CI: 0.94 to 0.98), but not ICU admission (aRR, 0.99; 95%CI: 0.96 to 1.01). Among patients admitted to ICU, vaccination was associated with a lower hazard of death (adjusted hazard ratio, 0.85; 95%CI: 0.78 to 0.92) and a 2-day reduction in the median time to discharge. Conclusion In this nationwide cohort study, influenza vaccination was associated with lower risks of IMV and in-hospital death among older adults hospitalized with influenza. These findings are consistent with possible attenuation of disease severity and support efforts to improve influenza vaccination among older adults. ### Competing Interest Statement BP is an employee of HEVA. CES and HB are full-time employees of Sanofi and may own shares and/or stock options in the company. MCN reports research grants from Sanofi; and personal fees from Pfizer and Sanofi. CNAC, ABD, AS, CC have no conflict of interest to declare. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: According to French regulations (Public Health Code Articles L.1461-3 and R.1461-11), research using pseudonymized data from the SNDS does not require ethics committee review or individual informed consent. Conducting the study did not require specific authorization form the French data protection authority. The study has been declared prior to data extraction on the Health Data Hub online platform (No. 24832545). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The clinical codes, data management, and analysis codes used in this study are available on request from the corresponding author. Access to the data dictionary and these anonymised data can be granted upon request to the French National Health Data System platform. ## Funder Information Declared Agence Nationale de la Recherche, ANR-23-CHIN-000201 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-ND 4.0 International license](http://creativecommons.org/licenses/by-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.10.26367727v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.06.04.26354935v2 "Elevated HbA1c is associated with advanced brain age in severe obesity") Posted November 12, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.10.26367727v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/12/2026.11.10.26367727.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.10.26367727v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/12/2026.11.10.26367727.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Influenza Vaccination and Disease Severity Among Older Adults Hospitalized with Influenza in France: A Nationwide Cohort Study, 2016-2024 Claire Nour Abou Chakra, Aby Ba Diallo, Andre Some, Baptiste Pitel, Helene Bricout, Clotilde EL GUERCHE-SEBLAIN, Cecile Chauvel, Marta Nunes medRxiv 2026.11.10.26367727; doi: https://doi.org/10.64898/2026.11.10.26367727 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.10.26367727v1%26text%3DInfluenza%2520Vaccination%2520and%2520Disease%2520Severity%2520Among%2520Older%2520Adults%2520Hospitalized%2520with%2520Influenza%2520in%2520France%253A%2520A%2520Nationwide%2520Cohort%2520Study%252C%25202016-2024 "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.10.26367727v1%26t%3DInfluenza%2520Vaccination%2520and%2520Disease%2520Severity%2520Among%2520Older%2520Adults%2520Hospitalized%2520with%2520Influenza%2520in%2520France%253A%2520A%2520Nationwide%2520Cohort%2520Study%252C%25202016-2024 "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.10.26367727v1%26title%3DInfluenza%2520Vaccination%2520and%2520Disease%2520Severity%2520Among%2520Older%2520Adults%2520Hospitalized%2520with%2520Influenza%2520in%2520France%253A%2520A%2520Nationwide%2520Cohort%2520Study%252C%25202016-2024%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.10.26367727v1%26title%3DInfluenza%2520Vaccination%2520and%2520Disease%2520Severity%2520Among%2520Older%2520Adults%2520Hospitalized%2520with%2520Influenza%2520in%2520France%253A%2520A%2520Nationwide%2520Cohort%2520Study%252C%25202016-2024 "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.10.26367727) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.10.26367727v1&count=horizontal&via=&text=Influenza%20Vaccination%20and%20Disease%20Severity%20Among%20Older%20Adults%20Hospitalized%20with%20Influenza%20in%20France%3A%20A%20Nationwide%20Cohort%20Study%2C%202016-2024&counturl=www.medrxiv.org/content/10.64898/2026.11.10.26367727v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (638) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (921) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (352) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5018) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (429) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (680) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1696) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16283) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1242) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7295) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (753) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1095) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5304) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1475) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1837) * [Hematology](https://www.medrxiv.org/collection/hematology) (599) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1383) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16502) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1203) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (701) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (157) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (754) * [Neurology](https://www.medrxiv.org/collection/neurology) (7617) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1132) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1297) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1041) * [Oncology](https://www.medrxiv.org/collection/oncology) (3752) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1096) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (411) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (468) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (503) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (143) * [Pathology](https://www.medrxiv.org/collection/pathology) (722) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1864) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (757) * [Primary Care Research](https://www.medrxiv.org/collection/primary-car
## Related Clinical Research

- [Maternal and Early-Life Obesity Impairs CD4+ T Cell Programming and Vaccine Responses](https://medichelpline.com/clinical-feed/nature-immunology-1-maternal-and-early-life-obesity-programs-cd4-t-cell-fate-to-impair-vaccine.md)
- [Washington resident dies after exposure to H5N1-infected dairy cattle](https://medichelpline.com/clinical-feed/stat-news-0-washington-state-resident-dies-from-bird-flu-following-exposure-to-infected.md)
- [Helen Branswell, veteran infectious disease reporter at STAT, dies at 69](https://medichelpline.com/clinical-feed/stat-news-0-helen-branswell-whose-reporting-on-infectious-diseases-and-public-health-drew.md)
- [Incidence of RSV in Adults ≥50 Years in the Upper Midwest After COVID-19: Community Cohort Finding](https://medichelpline.com/clinical-feed/bmj-open-6-incidence-of-respiratory-syncytial-virus-in-adults-50-years-during-and.md)
- [BNT162b2 KP.2 2024–2025 Vaccine Effectiveness Against COVID-19 Hospitalization and ED/UC Visits in](https://medichelpline.com/clinical-feed/pubmed-42594639.md) (DOI: 10.1016/j.vaccine.2026.129009)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.